Last Updated: June 17, 2026

PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for perfluoropolymethylisopropyl ether; polytetrafluoroethylene and what is the scope of freedom to operate?

Perfluoropolymethylisopropyl ether; polytetrafluoroethylene is the generic ingredient in one branded drug marketed by Us Army Med Res and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
DailyMed Link:PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE at DailyMed

US Patents and Regulatory Information for PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army Med Res SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS perfluoropolymethylisopropyl ether; polytetrafluoroethylene PASTE;TOPICAL 021084-001 Feb 17, 2000 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Army Med Res SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS perfluoropolymethylisopropyl ether; polytetrafluoroethylene PASTE;TOPICAL 021084-001 Feb 17, 2000 5,607,979 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Market Dynamics and Financial Trajectory for PERFLUOROPOLYMETHYLISOPROPYL ETHER and POLYTETRAFLUOROETHYLENE

Last updated: February 16, 2026


What Are These Chemicals and Their Primary Applications?

PERFLUOROPOLYMETHYLISOPROPYL ETHER and POLYTETRAFLUOROETHYLENE are fluorinated polymers used primarily in specialized industrial and consumer applications.

  • PERFLUOROPOLYMETHYLISOPROPYL ETHER: Acts as a solvent and a heat transfer fluid. It is valued for its thermal stability and chemical inertness, resistant to high temperatures and corrosion.

  • POLYTETRAFLUOROETHYLENE (PTFE): Commonly known as Teflon, used as a non-stick coating in cookware, in electrical insulation, and in high-performance gaskets and seals.


How Is the Market Shaping Up?

Market Size and Growth Forecast

  • The global fluoropolymer market stood at approximately USD 4.3 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 6% from 2023 to 2030, reaching around USD 7.1 billion in 2030[1].

  • PTFE accounts for nearly 70% of the fluoropolymer revenue, with the rest contributed by specialty fluoroethers like PERFLUOROPOLYMETHYLISOPROPYL ETHER.

  • Growth is driven by demand in electronics, chemical processing, and consumer goods sectors. The medical application segment is also expanding due to biocompatibility and inertness.

Regional Dynamics

  • North America: Largest market, driven by advanced manufacturing and electronics industries. The U.S. accounts for over 35% of global fluoropolymer consumption.

  • Asia-Pacific: Fastest-growing region, with CAGR estimates at 8%, influenced by industrial expansion in China, India, and Japan.

  • Europe: Steady growth; regulatory policies around environmental concerns influence the market trajectories.

Supply Chain and Price Trends

  • The market is concentrated with a handful of key producers, including Chemours, 3M, and Daikin.

  • Prices have experienced volatility due to raw material costs, particularly for fluorinated monomers like tetrafluoroethylene. Prices increased by approximately 10% in 2022, owing to supply chain disruptions and raw material shortages[2].


What Are Key Drivers and Challenges?

Drivers

  • Rising demand in electronics: PTFE's insulating properties make it essential for semiconductors, cables, and connectors.

  • Increased adoption in healthcare: Fluorinated compounds' inertness supports use in medical devices, implants, and diagnostic equipment.

  • Growth in industrial processes: Use of high-performance heat transfer fluids like PERFLUOROPOLYMETHYLISOPROPYL ETHER in chemical reactors.

Challenges

  • Environmental concerns: Persistent and bioaccumulative nature of some fluorinated chemicals results in regulatory restrictions. The EU's ban on certain PFAS substances impacts production and development.

  • Raw material constraints: Tetrafluoroethylene (TFE) required for PTFE manufacturing has supply limitations, affecting production capacities.

  • Cost pressures: Raw material and regulatory compliance costs push prices upward, pressuring margins.


What Is the Financial Outlook?

Revenue Projections and Investment Trends

  • Major companies are investing in R&D to develop environmentally friendly fluoropolymers. Chemours announced a USD 100 million expansion of its fluoropolymer capacity in 2022, focusing on sustainable fluoropolymers[3].

  • The fluoropolymer segment's profit margins range from 15% to 25%, depending on application and regional utility.

  • Entry barriers are high due to the complexity of synthesis and stringent environmental regulations, favoring established players.

Mergers, Acquisitions, and Patent Activity

  • Recent patent filings indicate increased R&D aimed at replacing traditional fluoropolymers with greener alternatives; however, no significant breakthroughs have yet disrupted market dominance.

  • Mergers and acquisitions, such as Chemours' acquisition of Teflon production rights, focus on maintaining market share amid regulatory pressures.


How Will Regulatory and Environmental Policies Affect Market Trajectory?

  • The European Green Deal and U.S. regulatory frameworks aim to phase out or restrict certain PFAS compounds, potentially reducing supply and increasing costs.

  • Industry shifts toward fluoropolymer alternatives, including non-perfluorinated polymers, are underway, possibly impacting long-term demand for traditional fluoropolymers.

  • Compliance investments are increasing as companies seek to meet environmental standards, influencing capital expenditure.


Key Takeaways

  • The fluoropolymer market is growing steadily, driven by electronics, healthcare, and industrial applications.

  • PTFE dominates revenue; specialty fluorinated compounds like PERFLUOROPOLYMETHYLISOPROPYL ETHER have niche but expanding markets.

  • Environmental regulations and raw material shortages pose risks; companies are investing in sustainable innovations.

  • Prices for fluoropolymers are volatile, influenced by raw material costs and regulatory compliance expenses.

  • Companies with established production capacity and R&D focus on environmental sustainability are most likely to remain competitive.


FAQs

1. What factors are most critical for investment in fluoropolymer manufacturing?
The key factors include technological advancements toward greener production, raw material supply stability, and regulatory climate favorability.

2. How do environmental regulations impact market growth?
Regulations limiting or banning certain PFAS reduce supply and increase compliance costs, constraining expansion but also encouraging innovation.

3. What are the main applications sustaining demand for PTFE?
Electronics insulation, non-stick cookware, and industrial gaskets maintain steady demand.

4. Are there viable substitutes for fluorinated chemicals like PERFLUOROPOLYMETHYLISOPROPYL ETHER?
Yes, research into non-fluorinated heat transfer fluids and polymers is ongoing, but replacement options remain limited in high-performance contexts.

5. What is the outlook for emerging markets?
Rapid industrialization in Asia-Pacific is expected to drive demand, though regulatory pressures may influence the pace of growth.


References

[1] MarketsandMarkets, “Fluoropolymer Market,” 2023.
[2] Chemours Investor Relations, “Q4 2022 Financial Supplement,” 2023.
[3] Chemours, “Capacity Expansion Investment Announcements,” 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.